Rezolute Shares Edge Higher Ahead of Key FDA Week
Rezolute Inc. shares ticked up in premarket trading Monday, with the gain coming ahead of a scheduled appearance by company executives at a healthcare event later this week. The shares were at $3.30, up 4 cents, with the rare-disease drug maker’s market cap around $343 million. This was before the regular Nasdaq open; the exchange lists pre-market hours from 4:00 a.m. to 9:30 a.m. Eastern.